Arcadia Biosciences Balance Sheet - Quarterly (NASDAQ:RKDA)

Add to My Stocks
$6.33 $0.75 (13.44%) RKDA stock closing price Aug 17, 2018 (Closing)

The fundamental analysis of this company requires a thorough look at Arcadia Biosciences balance sheet. A balance sheet can help evaluate the financial performance of a company. Ratios like return on total assets and current ratio, which also uses cash on hand can be used to measure the operating efficiency of a firm, and can be used to conduct a more accurate Arcadia Biosciences stock analysis. Good quarterly results indicate a company's strong financial performance. Its important to check all financial statements including the balance sheet. The Arcadia Biosciences balance sheet for 2018 Q2 shows total assets of $31.13M. The company has a asset turnover ratio of 0.07. Also see: Arcadia Biosciences revenue and Arcadia Biosciences operating cash flow for the same quarter.

View and download Arcadia Biosciences quarterly results to get the balance sheet details for the latest 40 quarters data.
show more
Quarterly
Annual
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q1
Cash9.67M20.41M9.12M2.93M13.43M7.55M2.01M10.47M27.36M29.54M
Marketable Securities18.93M-3.89M12.76M30.74M40.96M48.54M43.41M26.87M20.65M
Receivables--1.23M-------
Inventory----------
Raw Materials----------
Work In Progress----------
Finished Goods----------
Notes Receivable----------
Other Current Assets---1.09M1.48M1.28M-1.18M1.39M1.33M
Total Current Assets
29.97M21.24M15.04M17.16M46.51M50.44M52.22M55.67M56.19M52.53M
Property Plant & Equipment--5.18M---5.44M---
Accumulated Depreciation--4.88M---4.94M---
Net Property Plant & Equipment
----------
Investment & Advances------2.49M3.47M6.91M14.9M
Other Non-Current Assets-1.06M1.16M1.17M1.15M1.27M1.32M1.83M1.87M1.83M
Deferred Charges----------
Intangibles----------
Deposits & Other Assets----------
Total Assets
31.13M22.59M16.57M18.97M48.43M52.64M56.57M61.58M65.7M70.1M
Notes Payable----5.6M4.56M----
Accounts Payable2.44M2.45M2.49M1.86M1.83M2.18M2.35M2.61M2.57M2.79M
Current Portion Long-Term Debt----------
Current Portion Capital Leases----------
Accrued Expenses----------
Income Taxes Payable----------
Other Current Liabilities--1.02M----1.21M1.5M1.36M
Total Current Liabilities
2.92M3.03M3.52M2.52M6.69M5.17M3.12M3.82M4.07M4.15M
Mortgages----------
Deferred Taxes/Income--2.03M2.79M2.92M3.01M3.12M2.17M2.31M2.49M
Convertible Debt----------
Long-Term Debt----21.05M23.09M25.12M25.07M25.02M24.97M
Non-Current Capital Leases----------
Other Long-Term Liabilities20.08M18.9M3M3M3M3M3M3M3M3M
Total Liabilities
23M21.93M8.56M8.31M33.67M34.27M34.37M34.07M34.42M34.62M
Minority Interest----------
Preferred Stock----------
Common Stock Net----------
Capital Surplus190.26M176.12M175.22M174.92M174.5M174.11M173.72M173.31M172.91M172.58M
Retained Earnings-182.17M-175.5M-167.25M-164.29M-159.77M-155.76M-151.55M-145.84M-141.66M-137.11M
Treasury Stock----------
Other Liabilities-----0.01M-0.02M-0.01M-0.01M-0.01M-0.03M
Shareholders Equity8.13M-8M10.66M14.76M18.37M22.19M27.51M31.28M35.47M
Total Liabilities & Shareholders Equity31.13M22.59M16.57M18.97M48.43M52.64M56.57M61.58M65.7M70.1M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

Looking at Arcadia Biosciences historical stock prices and the current Arcadia Biosciences stock price can tell you how the stock price has moved, whereas the Arcadia Biosciences PE ratio chart shows if its shares are overpriced in comparison to peers. The important things to look for in a balance sheet are:

  • Assets: RKDA total assets, which was at $31.13M for 2018 Q2 is a balance sheet item representing value of what Arcadia Biosciences owns. Assets are brought to aid a firms operations, or to increase its economic value. It must be noted that tech stocks may not have a lot of assets, as the value for these companies is often derived from future earning potential.
  • Liabilities: The total liabilities of Arcadia Biosciences for the quarter 2018 Q2 total to $23M. Liabilities for a company like Arcadia Biosciences include bank loans, services which have been availed for which a settlement in the form of cash/ asset transfer needs to be done in future etc. A firm takes on such obligations to grow its business which in turn will generate future economic benefits for its business.

Arcadia Biosciences Balance Sheet - Key Ratios

Current ratio
10.26
Debt to equity ratio
0
Asset turnover ratio
0.07
Receivables turnover
5.75
Price to book ratio
2.48